MX340107B - Metodo de medicion inmunologica para precurso de peptido que libera gastrina. - Google Patents

Metodo de medicion inmunologica para precurso de peptido que libera gastrina.

Info

Publication number
MX340107B
MX340107B MX2012011711A MX2012011711A MX340107B MX 340107 B MX340107 B MX 340107B MX 2012011711 A MX2012011711 A MX 2012011711A MX 2012011711 A MX2012011711 A MX 2012011711A MX 340107 B MX340107 B MX 340107B
Authority
MX
Mexico
Prior art keywords
gastrin
measurement method
releasing peptide
sample
peptide precursor
Prior art date
Application number
MX2012011711A
Other languages
English (en)
Inventor
Yoshimura Toru
Fujita Kenju
L Dowell Barry
Original Assignee
Abbott Laboratories *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories * filed Critical Abbott Laboratories *
Publication of MX340107B publication Critical patent/MX340107B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5758—Gastrin releasing peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a estabilidad del ProGRP el cual se sabe que es inestable en una muestra biológica y proporciona un método para medir el ProGRP con más precisión y de manera más simple. Se usa una muestra de sangre en la cual se inactiva un factor de coagulación de la sangre. Se puede inhibir la degradación del ProGRP, y se pueden mejorar la estabilidad de almacenamiento prolongado de la muestra y la precisión de la medición.
MX2012011711A 2006-12-11 2007-12-11 Metodo de medicion inmunologica para precurso de peptido que libera gastrina. MX340107B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006333072A JP5201822B2 (ja) 2006-12-11 2006-12-11 ガストリン放出ペプチド前駆体の免疫学的測定方法
PCT/JP2007/073854 WO2008072621A1 (ja) 2006-12-11 2007-12-11 ガストリン放出ペプチド前駆体の免疫学的測定方法

Publications (1)

Publication Number Publication Date
MX340107B true MX340107B (es) 2016-06-27

Family

ID=39511642

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012011711A MX340107B (es) 2006-12-11 2007-12-11 Metodo de medicion inmunologica para precurso de peptido que libera gastrina.
MX2009006168A MX2009006168A (es) 2006-12-11 2007-12-11 Metodo de medicion inmunologica para precursor de peptido que libera gastrina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2009006168A MX2009006168A (es) 2006-12-11 2007-12-11 Metodo de medicion inmunologica para precursor de peptido que libera gastrina.

Country Status (6)

Country Link
US (3) US20100136711A1 (es)
EP (1) EP2103938B1 (es)
JP (1) JP5201822B2 (es)
ES (1) ES2601028T3 (es)
MX (2) MX340107B (es)
WO (1) WO2008072621A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5201822B2 (ja) 2006-12-11 2013-06-05 アボット・ラボラトリーズ ガストリン放出ペプチド前駆体の免疫学的測定方法
FI20115367A0 (fi) * 2011-04-15 2011-04-15 Hytest Oy Menetelmä sydän- ja verisuonitapahtumien määrittämiseksi käyttämällä IGFBP-fragmentteja
CN108333360A (zh) * 2017-01-19 2018-07-27 深圳市新产业生物医学工程股份有限公司 胃泌素释放肽前体稀释液及其应用和试剂盒
CN108107224A (zh) * 2017-12-18 2018-06-01 郑州安图生物工程股份有限公司 一种ProGRP含量测定用液态校准品
CN108279307B (zh) * 2018-01-30 2021-01-26 郑州安图生物工程股份有限公司 保护和稳定血清或血浆中胃泌素释放肽前体的采血管
CN108982858B (zh) * 2018-07-05 2021-06-15 陕西师范大学 一种基于单克隆抗体检测人proGRP的双夹心ELISA试剂盒
CN109342728A (zh) * 2018-10-18 2019-02-15 郑州标源生物科技有限公司 一种适用肿瘤标志物Pro-GRP定量检测的质控品

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256540A (en) * 1990-12-28 1993-10-26 Mayo Foundation For Medical Education And Research Immunoassay for small cell lung carcinoma
JP3210994B2 (ja) * 1992-06-12 2001-09-25 株式会社先端生命科学研究所 ヒトガストリン放出ペプチド前駆体に対する抗体及びその使用
CA2089212C (en) * 1992-06-12 2004-01-20 Ken Yamaguchi Antibodies to human gastrin-releasing peptide precusor and use thereof
JP2003270238A (ja) * 2002-03-14 2003-09-25 Sanyo Chem Ind Ltd 体液検査用具
CA2604608C (en) * 2005-04-13 2013-11-19 Advanced Life Science Institute, Inc. Antibody directed against gastrin-releasing peptide precursor and use thereof
US20080233567A1 (en) * 2006-09-05 2008-09-25 Murray William E Companion diagnostic assays for cancer therapy
WO2008029965A1 (en) * 2006-09-08 2008-03-13 Peoplebio, Inc. Simultaneous reaction assay for differentially detecting multimeric form
JP5201822B2 (ja) 2006-12-11 2013-06-05 アボット・ラボラトリーズ ガストリン放出ペプチド前駆体の免疫学的測定方法

Also Published As

Publication number Publication date
JP2008145278A (ja) 2008-06-26
JP5201822B2 (ja) 2013-06-05
US10067124B2 (en) 2018-09-04
US9459248B2 (en) 2016-10-04
MX2009006168A (es) 2009-06-19
EP2103938A4 (en) 2010-06-30
ES2601028T3 (es) 2017-02-14
EP2103938A1 (en) 2009-09-23
US20170089889A1 (en) 2017-03-30
WO2008072621A1 (ja) 2008-06-19
US20140287532A1 (en) 2014-09-25
EP2103938B1 (en) 2016-08-31
US20100136711A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
MX2009006168A (es) Metodo de medicion inmunologica para precursor de peptido que libera gastrina.
UA116618C2 (uk) СКОНСТРУЙОВАНЕ НА ОСНОВІ ЦИСТЕЇНУ АНТИТІЛО ПРОТИ CD79b
BR112012031166A2 (pt) compensação baseada eminclinação incluindo sinais de saída secundários
EP2073706A4 (en) TISSUE PERFUSION ANALYSIS SYSTEM BASED ON THE USE OF INDOCYANINE GREEN CONCENTRATION IN BLOOD
WO2006109279A3 (en) Analyte determination method and analyte meter
WO2008078781A1 (ja) ヘモグロビン類の測定方法及び電気泳動装置
BR112014016232A8 (pt) medições precisas de analito para tira de teste eletroquímico com base em múltiplas medições discretas definidas pela(s) característica(s) física(s) detectada(s) da amostra contendo o analito
WO2009075306A1 (ja) 発光測定方法および発光測定システム
MX342178B (es) Kit guiado de prueba estructurada.
WO2009057293A1 (ja) ヘモグロビン及びヘモグロビン誘導体の測定方法、測定キット
UY29918A1 (es) Reactivo para sensores de prueba que contiene polimeros de celulosa
MY196578A (en) Method for Determining Stage of Periodontal Disease
CN103033603B (zh) 包裹式连接器
CN101082575A (zh) 柠檬酸浓度的测定方法及柠檬酸诊断试剂盒
EP1988164A4 (en) METHOD FOR TESTING THE SENSITIVITY OF SOLIC CANCER AGAINST A TYROSINE KINASE INHIBITOR AND CORRESPONDING TEST REQUIREMENTS
WO2014118543A3 (en) Electrochemical total protein detection system
WO2011128079A3 (en) Lacosamide detection assay
CN204422409U (zh) 一种缺血修饰白蛋白测定试剂盒
WO2013036064A3 (ko) 세포질 원액에서의 단백질 농도 측정 방법
UA60444U (ru) Способ определения витамина с в клетках крови лошадей
WO2011049442A3 (en) Blood coagulation status measurement in saliva
RU2007124565A (ru) Биолюминесцентный способ определения антиоксидантной активности гуминовых веществ
CN101464329A (zh) 硒诊断/测定试剂盒及硒的浓度测定方法
CN105136703A (zh) 一种红细胞脆性测定试剂盒及其使用方法
BR112013015394A2 (pt) método de determinar a presença ou a ausência, em uma amostra biológica de um paciente, de células de câncer de bexiga ou próstata, composto, e, uso de um composto